SCHEMBL29699144

SCHEMBL29699144

CC(C)(C)OC(=O)N1CC2(CC[C@H]2N)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
USP2 O75604 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM1A O60341 2/20 0.40
RECQL P46063 1/20 0.39
EPHX1 P07099 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
NR1H2 P55055 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
EPHX2 P34913 1/20 0.38
GPR119 Q8TDV5 3/20 0.37
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN6 P29350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19332014 1.00 HPGD (0.41) HPGDUSP2SMN1; SMN2KDM1ARECQL
Hydrochloric Acid SCHEMBL29699111 0.98 HPGD (0.40) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL16044435 0.89 HPGD (0.41) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL16042188 0.87 HPGD (0.46) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL16042190 0.87 HPGD (0.46) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL16042332 0.87 HPGD (0.46) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL23826942 0.86 HPGD (0.47) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL15769569 0.86 HPGD (0.47) HPGDUSP2SMN1; SMN2KDM1ARECQL
SCHEMBL28622796 0.86 HPGD (0.47) HPGDUSP2SMN1; SMN2KDM1ARECQL
Hydrochloric Acid SCHEMBL30803165 0.84 HPGD (0.46) HPGDUSP2SMN1; SMN2KDM1ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124504-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF EXSCIENTIA AI LIMITED (GB) 2024-04-18 US disclosed
EP-4269403-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF GT Apeiron Therapeutics Limited (HK) 2023-11-01 EP disclosed
CN-116745277-A Aromatic heterocyclic compound, pharmaceutical composition and application thereof 湃隆生物科技有限公司(香港) 2023-09-12 CN disclosed
WO-2022134642-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 湃隆生物科技有限公司(香港) 2022-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124504-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF CDK7, CDK17, CDK8 HPGD 2765/4885USP2 3792/4885SMN1; SMN2 3441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.